132 results
6-K
EX-99.2
THTX
Theratechnologies Inc.
15 Apr 24
Notice of Annual Meeting of Shareholders
9:31am
provides for the reimbursement of all reasonable expenses incurred by each director who are not employed on a full-time basis by the Corporation
6-K
EX-99.2
THTX
Theratechnologies Inc.
10 Apr 24
Interim Consolidated Financial Statements
8:30am
additional collaboration agreements; our success in continuing to seek and in maintaining reimbursement for EGRIFTA SV® and Trogarzo® by third-party … payors in the United States; the pricing and reimbursement conditions of other competing drugs or therapies that are or may become available; our
F-3
hul0msx9ol80 gszyt
21 Dec 23
Shelf registration (foreign)
1:21pm
6-K
EX-99.1
mgc2cr9
26 Oct 23
Current report (foreign)
9:15pm
SUPPL
17unbl6nm u07dxbp12u
26 Oct 23
Supplemental materials (foreign)
9:13pm
SUPPL
70oyrddwnv0se09go99p
25 Oct 23
Supplemental materials (foreign)
6:56pm